BVX-001

N/A

Report date: 2024/04/23 13:52:26

Base Information

Drug NameBVX-001
Drug Alias NameBVX 001BVX-001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody
Mechanisms of ActionTubulin polymerisation inhibitorsMyeloid cell surface antigen CD33 modulatorsT-cell antigen CD7 modulators
TargetsTubulinMyeloid cell surface antigen CD33T-cell antigen CD7
Therapy Area/IndicationsLeukemia, Myeloid, Acute
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBiVictriX Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesIontasBiVictriX Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsLeukemia, Myeloid, Acute
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A